Optimind Pharma Corp. Stock OTC Markets
Equities
LOONF
CA68405U1012
Biotechnology & Medical Research
Sales 2022 | 99.69K 73.11K | Sales 2023 | 170K 125K | Capitalization | 3.91M 2.87M |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | -3M -2.2M | EV / Sales 2022 * | - |
Net cash position 2022 | 1.22M 894K | Net Debt 2023 | 61.19K 44.88K | EV / Sales 2023 | 23.4 x |
P/E ratio 2022 * |
-
| P/E ratio 2023 |
-1.07
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 92.31% |
1st Jan change | Capi. | |
---|---|---|
+8.29% | 114B | |
+10.21% | 104B | |
-11.90% | 22.41B | |
+0.20% | 22.28B | |
-5.57% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |